The Gross Law Firm
NEW YORK, NY / ACCESSWIRE / July 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Contextlogic Inc. (NASDAQ:WISH)
This lawsuit is on behalf of: i) all persons or entities who purchased or otherwise acquired securities of ContextLogic, Inc. ("ContextLogic") (NASDAQ: WISH) and/or sold put options of ContextLogic during the period from December 16, 2020 to May 12, 2021, inclusive; and/or (ii) all persons who purchased ContextLogic securities pursuant and/or traceable to the Company's initial public offering conducted on or about December 16, 2020.
A class action has commenced on behalf of certain shareholders in Contextlogic Inc. In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic's business operations and financial prospects by overstating its then-present monthly active users ("MAUs") and MAU growth trends.
Shareholders may find more information at https://securitiesclasslaw.com/securities/contextlogic-inc-loss-submission-form/?id=17691&from=1
Frequency Therapeutics, Inc. (NASDAQ:FREQ)
Investors Affected: November 16, 2020 - March 22, 2021
A class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.
Shareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17691&from=1
RLX Technology Inc. (NYSE:RLX)
This lawsuit is on behalf of persons who purchased, or otherwise acquired, RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX's January 2021 initial public stock offering.
A class action has commenced on behalf of certain shareholders in RLX Technology Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's then-existing exposure to China's ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX's reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.
Shareholders may find more information at https://securitiesclasslaw.com/securities/rlx-technology-inc-loss-submission-form/?id=17691&from=1
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
https://www.accesswire.com/655759/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-WISH-FREQ-and-RLX
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Cytta Corp.22.4.2024 14:04:16 CEST | Press release
Cytta Corp. to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024
Moolec Science SA22.4.2024 12:02:52 CEST | Press release
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins
Moment Factory19.4.2024 22:17:28 CEST | Press release
Phish Live at Sphere: Moment Factory Harnesses Sphere's Next-Generation Technologies to Reimagine Concert Experience
Seyond18.4.2024 12:03:28 CEST | Press release
Seyond's High-Performance LiDAR Technology Powers the Future of Autonomous Racing
Loar Holdings, LLC17.4.2024 12:32:14 CEST | Press release
Loar Announces Launch of Initial Public Offering
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom